Interstitial Fibrosis Quantification in Renal Transplant Recipients Randomized to Continue Cyclosporine or Convert to Sirolimus (pages 2552–2560)
A. Servais, V. Meas-Yedid, O. Toupance, Y. Lebranchu, A. Thierry, B. Moulin, I. Etienne, C. Presne, De Ligny B. Hurault, P. Le Pogamp, Y. Le Meur, D. Glotz, C. Hayem, J. C. Olivo Marin and E. Thervet
Article first published online: 15 OCT 2009 | DOI: 10.1111/j.1600-6143.2009.02803.x
In this multicenter, randomized, prospective trial, kidney transplant patients converted from cyclosporine to sirolimus had improvemed renal function at one year, but biopsy results showed no between-group difference in interstitial fibrosis quantified automatically by a program of color segmentation.